Human JUN/AP1/c-Jun ORF/cDNA clone-Lentivirus plasmid (BC006175)
Cat. No.: pGMLP-SPh-129
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human JUN/AP1/c-Jun Lentiviral expression plasmid for JUN lentivirus packaging, JUN lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
JUN/AP1 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP-SPh-129 |
| Gene Name | JUN |
| Accession Number | BC006175 |
| Gene ID | 3725 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 996 bp |
| Gene Alias | AP1,c-Jun |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGACTGCAAAGATGGAAACGACCTTCTATGACGATGCCCTCAACGCCTCGTTCCTCCCGTCCGAGAGCGGACCTTATGGCTACAGTAACCCCAAGATCCTGAAACAGAGCATGACCCTGAACCTGGCCGACCCAGTGGGGAGCCTGAAGCCGCACCTCCGCGCCAAGAACTCGGACCTCCTCACCTCGCCCGACGTGGGGCTGCTCAAGCTGGCGTCGCCCGAGCTGGAGCGCCTGATAATCCAGTCCAGCAACGGGCACATCACCACCACGCCGACCCCCACCCAGTTCCTGTGCCCCAAGAACGTGACAGATGAGCAGGAGGGCTTCGCCGAGGGCTTCGTGCGCGCCCTGGCCGAACTGCACAGCCAGAACACGCTGCCCAGCGTCACGTCGGCGGCGCAGCCGGTCAACGGGGCAGGCATGGTGGCTCCCGCGGTAGCCTCGGTGGCAGGGGGCAGCGGCAGCGGCGGCTTCAGCGCCAGCCTGCACAGCGAGCCGCCGGTCTACGCAAACCTCAGCAACTTCAACCCAGGCGCGCTGAGCAGCGGCGGCGGGGCGCCCTCCTACGGCGCGGCCGGCCTGGCCTTTCCCGCGCAACCCCAGCAGCAGCAGCAGCCGCCGCACCACCTGCCCCAGCAGATGCCCGTGCAGCACCCGCGGCTGCAGGCCCTGAAGGAGGAGCCTCAGACAGTGCCCGAGATGCCCGGCGAGACACCGCCCCTGTCCCCCATCGACATGGAGTCCCAGGAGCGGATCAAGGCGGAGAGGAAGCGCATGAGGAACCGCATCGCTGCCTCCAAGTGCCGAAAAAGGAAGCTGGAGAGAATCGCCCGGCTGGAGGAAAAAGTGAAAACCTTGAAAGCTCAGAACTCGGAGCTGGCGTCCACGGCCAACATGCTCAGGGAACAGGTGGCACAGCTTAAACAGAAAGTCATGAACCACGTTAACAGTGGGTGCCAACTCATGCTAACGCAGCAGTTGCAAACATTTTGA |
| ORF Protein Sequence | MTAKMETTFYDDALNASFLPSESGPYGYSNPKILKQSMTLNLADPVGSLKPHLRAKNSDLLTSPDVGLLKLASPELERLIIQSSNGHITTTPTPTQFLCPKNVTDEQEGFAEGFVRALAELHSQNTLPSVTSAAQPVNGAGMVAPAVASVAGGSGSGGFSASLHSEPPVYANLSNFNPGALSSGGGAPSYGAAGLAFPAQPQQQQQPPHHLPQQMPVQHPRLQALKEEPQTVPEMPGETPPLSPIDMESQERIKAERKRMRNRIAASKCRKRKLERIARLEEKVKTLKAQNSELASTANMLREQVAQLKQKVMNHVNSGCQLMLTQQLQTF |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T69085-Ab | Anti-JUN monoclonal antibody |
| Target Antigen | GM-Tg-g-T69085-Ag | JUN protein |
| ORF Viral Vector | pGMLP005587 | Human JUN Lentivirus plasmid |
| ORF Viral Vector | pGMLV000295 | Human JUN Lentivirus plasmid |
| ORF Viral Vector | pGMLV001471 | Human JUN Lentivirus plasmid |
| ORF Viral Vector | pGMAD000140 | Human JUN Adenovirus plasmid |
| ORF Viral Vector | pGMAD000912 | Human JUN Adenovirus plasmid |
| ORF Viral Vector | pGMAD001483 | Human JUN Adenovirus plasmid |
| ORF Viral Vector | pGMAP000535 | Human JUN Adenovirus plasmid |
| ORF Viral Vector | pGMLP-SPh-129 | Human JUN Lentivirus plasmid |
| ORF Viral Vector | pGMAP-SPh-269 | Human JUN Adenovirus plasmid |
| ORF Viral Vector | pGMPC000142 | Human JUN Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP005587 | Human JUN Lentivirus particle |
| ORF Viral Vector | vGMLV000295 | Human JUN Lentivirus particle |
| ORF Viral Vector | vGMLV001471 | Human JUN Lentivirus particle |
| ORF Viral Vector | vGMAD000140 | Human JUN Adenovirus particle |
| ORF Viral Vector | vGMAD000912 | Human JUN Adenovirus particle |
| ORF Viral Vector | vGMAD001483 | Human JUN Adenovirus particle |
| ORF Viral Vector | vGMAP000535 | Human JUN Adenovirus particle |
| ORF Viral Vector | vGMLP-SPh-129 | Human JUN Lentivirus particle |
| ORF Viral Vector | vGMAP-SPh-269 | Human JUN Adenovirus particle |
Target information
| Target ID | GM-T69085 |
| Target Name | JUN |
|
Gene Group Identifier (Target Gene ID in Homo species) |
3725 |
| Gene ID |
100067469 (Equus caballus), 101097261 (Felis catus), 16476 (Mus musculus), 24516 (Rattus norvegicus) 280831 (Bos taurus), 3725 (Homo sapiens), 609429 (Canis lupus familiaris), 716452 (Macaca mulatta) |
| Gene Symbols & Synonyms | JUN,Jun,AP-1,Junc,c-jun,AP1,p39,cJUN,c-Jun |
| Target Alternative Names | AP-1,AP1,Activator protein 1 (AP1),JUN,Jun,Junc,Proto-oncogene c-Jun,Transcription factor AP-1 subunit Jun,Transcription factor Jun,V-jun avian sarcoma virus 17 oncogene homolog,c-Jun,c-jun,cJUN,p39 |
| Uniprot Accession |
O77627,P05412,P05627,P17325
Additional SwissProt Accessions: P05627,P17325,O77627,P05412 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | cancer |
| Disease from KEGG | Endocrine resistance, MAPK signaling pathway, ErbB signaling pathway, cAMP signaling pathway, Apoptosis, Wnt signaling pathway, Osteoclast differentiation, Focal adhesion, Tight junction, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, C-type lectin receptor signaling pathway, IL-17 signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, TNF signaling pathway, Neurotrophin signaling pathway, GnRH signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Cocaine addiction, Amphetamine addiction, Epithelial cell signaling in Helicobacter pylori infection, Pathogenic Escherichia coli infection, Pertussis, Yersinia infection, Leishmaniasis, Chagas disease, Hepatitis B, Measles, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Epstein-Barr virus infection, Pathways in cancer, Chemical carcinogenesis - receptor activation, Colorectal cancer, Renal cell carcinoma, Breast cancer, Choline metabolism in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Inflammatory bowel disease, Rheumatoid arthritis, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis |
| Gene Ensembl | ENSECAG00000024055, ENSMUSG00000052684, ENSG00000177606, ENSCAFG00845006541, ENSMMUG00000059326 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


